Cristina Rodríguez, PhD, Preclinical Imaging Facility Manager, UBC Molecular Imaging Research Facility (MIRF)

Cristina Rodríguez PhD

Preclinical Imaging Facility Manager · Translational Imaging Scientist · Research Software Builder Molecular Imaging Research Facility (MIRF), Centre for Comparative Medicine The University of British Columbia Vancouver, Canada

I run UBC's preclinical PET, SPECT and CT facility, and build what it takes to move a study from molecule to image to evidence.

I connect translational imaging science with the operations, technology and institutional structure that make it work. MIRF, the Molecular Imaging Research Facility, is the University of British Columbia's small-animal in vivo imaging facility, with SPECT, PET and CT on one platform. I lead its scientific direction and service model, budget and pricing, radiation-safety and animal-ethics compliance, people and partnerships, serving research groups across UBC, TRIUMF, SFU, BC Cancer and BC Children's Hospital. I work alongside the facility's academic co-directors, Profs. Vesna Sossi (UBC Physics and Astronomy) and Urs Häfeli (UBC Pharmaceutical Sciences).

I am a chemist by training, an imaging scientist by trade, and I write software when the lab needs a tool that does not exist yet. I also design the figures, posters and web pages that communicate the facility's science and work.

Building and leading MIRF

A research facility is a small organisation embedded inside a much larger one. Running one means holding science, operations and strategy together at the same time.

Strategy & infrastructure

  • Helped turn a single research group's scanner into a shared preclinical imaging facility, building the operating model around it: service design, pricing, capacity and long-term infrastructure planning.
  • Lead the budget and financial planning of a facility that runs on a cost-recovery model, with no departmental or faculty funding; secured competitive infrastructure funding (UBC Research Facilities Support Grant 2020, NSERC RTI 2025).
  • Report to institutional and scientific oversight bodies, including TRIUMF's Life Sciences committee.
  • Build the partnerships that bring studies in: UBC, TRIUMF, SFU, BC Cancer, BC Children's Hospital.

Operations & compliance

  • Built the workflows that connect study design, radiochemistry, animal work, imaging, quantitative analysis and reporting.
  • Accountable for radiation safety, animal ethics and institutional compliance across every study.
  • Run the instrument lifecycle, scheduling and logistics: QC, calibration, service contracts, vendor relationships, isotope supply and study documentation.
  • Lead and develop the technical team, and train the students and users who work in the lab.

Imaging science & training

  • Developed the facility's quantitative imaging methodology: calibration, cross-calibration, %ID/g and dosimetry workflows.
  • Guide investigators from study design to interpretation, so the imaging answers the question they actually asked.
  • Co-instructor of PHAR 518 (Faculty of Pharmaceutical Sciences) since 2015; lead of the facility's annual hands-on imaging workshops and one-on-one analysis training; lead trainer for optical imaging (Lago X) in Pharmaceutical Sciences.
  • Helped two other UBC laboratories establish optical imaging and microCT capabilities.
2014At MIRF since 2014; leading it since 2020
5Imaging modalities across 3 UBC facilities: PET, SPECT, CT, optical, microCT
17+Research groups supported, across 5 institutions
25Active projects in the latest programme report

Research

Making what happens inside a living system measurable, reproducible, and useful for developing new radiopharmaceuticals and therapies.

Quantitative preclinical imaging

PET, SPECT and CT quantification, calibration, cross-calibration and longitudinal imaging: the methodology that makes imaging numbers trustworthy.

Radionuclide theranostics

Preclinical imaging and biodistribution of emerging therapeutic radionuclides and theranostic pairs, from actinium-225 to mercury-197m/g, terbium and erbium.

Image-based dosimetry

Quantitative imaging workflows that connect where activity goes to the absorbed dose it delivers.

Drug delivery & biodistribution

SPECT/CT evaluation of peptides, antibodies, polymers, nanoparticles, lipid nanoparticles and inhaled aerosols.

61peer-reviewed publications Selected papers and the complete list

LabTools

Software for the lab that had to be written because it did not exist.

LabTools is an independent software initiative born inside a working imaging facility. Every tool began as a real bottleneck: a figure that took a day to assemble, an isotope log kept on paper, an SOP nobody could find, a transfer request buried in email. I write the tool, the facility puts it to work, and when it is solid enough it is released so other labs can use it too.

9tools, from image analysis to operations
3open source on GitHub
Dailyin use at a working imaging facility
Freeto try; several free for academic groups

Journey

One thread, three chapters: designing molecules to see disease, running the scanners that image them, and writing the software that measures what they show.

01
2003 to 2009Barcelona, Spain

Foundations: chemistry for seeing disease

I trained as a chemist at the Universitat Autònoma de Barcelona: an MSc with the highest distinction, then a PhD in medicinal and bioinorganic chemistry, graded Excel·lent cum laude, while teaching full-time as a Professora Ajudant in the Department of Chemistry. My doctoral work asked a question that has followed me ever since: can we design small molecules that bind the metal ions and amyloid aggregates behind Alzheimer's disease and be seen inside a living body? The research was carried out in the UAB Department of Chemistry: synthesis, metal-protein titrations, spectroscopy and computational screening. Two research stays at leading Barcelona institutes complemented it: at ICMAB-CSIC, organic chemistry and my first hands-on radiochemistry, labelling molecules with technetium-99m and iodine-123 for in vivo imaging; and at IQS, amyloid peptide studies, intercalation and fluorescence.

  • MSc, Chemistry (Matrícula d'Honor)
    Universitat Autònoma de Barcelona · 2003 to 2005
  • Professora Ajudant (Assistant Lecturer)
    UAB Department of Chemistry · Sep 2005 to Sep 2009
  • PhD, Medicinal and Bioinorganic Chemistry (Excel·lent cum laude)
    Universitat Autònoma de Barcelona · 2005 to 2009
  • Visiting Researcher, radiochemistry
    ICMAB-CSIC · Feb 2004 to Jun 2006
  • Visiting Researcher, amyloid disease
    IQS Barcelona · Mar to Jul 2007
  • J. Am. Chem. Soc. · 2009 · a key paper from my doctoral research
  • Analytical Chemist, industry placement during my degree
    Ingeniería Analítica S.L. · Feb to Jul 2003
Molecules designed to be seen need scanners to see them, and a lab that can evaluate them in living systems.
02
2010 to 2014Vancouver, Canada

From molecules to images

A Beatriu de Pinós fellowship brought me to UBC with independent funding to push the same radiotracer idea toward the clinic: synthesizing theranostic candidates for Alzheimer's disease and evaluating them in live cells, against proteins and enzymes, and for toxicity. In parallel I went deeper into computation, applying DFT, molecular docking and virtual screening first to my own Alzheimer's molecules and later to cannabinoid CB2 agonists with the Faculty of Pharmaceutical Sciences. I also took stock of the field: a review in Coordination Chemistry Reviews mapping the molecular scaffolds for metal-targeting Alzheimer's therapeutics was listed among ScienceDirect's most-downloaded articles for the journal. This is the period when evaluating a compound stopped meaning a spectrum and started meaning an image, and when the Alzheimer's Drug Discovery Foundation recognized the work with a Young Investigator Scholarship.

I had molecules ready to go in vivo. What I did not have was anywhere to image them.
03
2014 to todayVancouver, Canada

Making the facility the place I once needed

By the end of my postdoc, the cell assays, binding studies and toxicity work were done, and my molecules were ready for the last step: into a living animal, on a preclinical scanner. I could not take it. UBC's preclinical imaging lab at the Centre for Comparative Medicine, founded in 2012 by Profs. Vesna Sossi and Urs Häfeli and Dr. Paul Schaffer of TRIUMF around a VECTor/CT scanner, was still being built, and it was not yet clear whether it would be a shared resource at all. The pieces a researcher needs for that step, the radiochemistry, the animal protocols, the scanner operator, someone who could quantify the image and also understand the pharmacokinetics of a radiotracer, were scattered across people who did not yet speak the same scientific language. So when a position opened there in 2014, I applied with one idea in mind: make this the place where the puzzle is already assembled, so that the next researcher walking in would find all the pieces together, from the design of the experiment to the analysis of the data.

I joined as lab manager and research associate and helped build the PET, SPECT and CT platform into a reproducible, quantitative operation. From 2015 I also brought that work into the classroom as co-instructor of PHAR 518. As word spread, what had started as one research group's scanner became a shared resource, for groups across UBC, then other local institutions, then academic centres and companies abroad, and the lab became the Molecular Imaging Research Facility, running on a cost-recovery model from the start. The 2020 MILabs Image of the Year came out of this work.

In December 2020 my role was formalized as the facility's manager. Profs. Sossi and Häfeli remain its academic co-directors, and their mentorship has shaped both the scientist and the manager I became. Within that partnership I lead the facility's day-to-day direction, and its operating model has since travelled beyond MIRF: I helped two other UBC laboratories, an optical imaging platform and a new microCT facility, through their set-up and first year. And because the bottlenecks that once stopped me were the same ones stopping my users, I built the software to remove them, which became LabTools.

  • Lab Manager and Research Associate, Preclinical Nuclear Imaging
    The University of British Columbia · Oct 2014 to Dec 2020
  • Co-instructor, PHAR 518
    UBC Faculty of Pharmaceutical Sciences · since 2015
  • WMIC MOMIL grant for leaders of imaging facilities
    World Molecular Imaging Congress · 2019
  • MILabs Image of the Year, Laboratory Award
    2020
  • Preclinical Imaging Facility Manager, MIRF
    UBC Centre for Comparative Medicine · Dec 2020 to present
  • Funding secured for the platform
    UBC Research Facilities Support Grant 2020 · NSERC RTI 2025
  • Optical Imaging Specialist and Lead Trainer, Lago X
    UBC Faculty of Pharmaceutical Sciences · 2024 to present
  • microCT Imaging Advisor (MILabs)
    The University of British Columbia · 2024 to 2025

Publications

From the bench to the scanner: molecules for neurodegenerative disease, then the imaging that measures them.

61Peer-reviewed publications
2007–26Years publishing
42Journals
5Research themes

Selected papers the turning points

Complete list filter by theme, year or keyword; every entry links to its DOI

Get in touch

Let's work together

Planning a preclinical imaging study? Building a research facility? Looking for a better way to run a laboratory workflow? I work across all three, and I would be glad to talk.